drugset / Trial / NCT00867698
AST-120 Used to Treat Mild Hepatic Encephalopathy
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether AST-120 is safe and effective in the treatment of mild hepatic encephalopathy.
Timeline
- Start
- 2009-03
- Primary completion
- 2010-04
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Activated Charcoal | Other / unclassified | 2 g | — |
| Subject | Activated Charcoal | Other / unclassified | 4 g | — |